Exogenous factors influencing endogenous inflammation: What can patients do to improve control of their own uveitis?

British Journal of Ophthalmology

Volumn 94, Issue 7, 2010, Pages 813-814

  Cunningham Jr , Emmett T ^a,b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; HLA ANTIGEN;

B LYMPHOCYTE; CYTOKINE PRODUCTION; EDITORIAL; EYE INFLAMMATION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; MENTAL STRESS; PATHOGENESIS; PRIORITY JOURNAL; SCLERITIS; SMOKING; T LYMPHOCYTE ACTIVATION; UVEITIS;

ADULT; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; SELF CARE; SMOKING; SMOKING CESSATION; UVEITIS; YOUNG ADULT;

EID: 77954290014     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.178780     Document Type: Editorial

References (32)

1. Schewitz-Bowers LP, Lee RWJ, Dick AD. Immune mechanisms of intraocular inflammation. Expert Rev Ophthalmol 2010;5:43-58.
2. Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin Immunopathol 2008;30:135-43.
3. Mochizuki M. Regional immunity of the eye. Acta Ophthalmologica 2009 Nov 7, [Epub ahead of print].
4. Bora NS, Jha P, Bora PS. The role of complement in ocular pathology. Semin Immunopathol 2008;30: 85-95.
5. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 2007;44:3901-8.
6. Wakefield D, Gray P, Chang J, et al. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Br J Ophthalmol 2010;94:271-4.
7. Franke GH, Schütte E, Heiligenhaus A. Rehabilitationepsychological aspects of uveitis. Psychother Psychosom Med Psychol 2005;55:65-71.
8. Carrim ZI, Ahmed TY, Taguir AH. The relationship between stress and acute anterior uveitis. Acta Ophthalmol Scand 2006;84:795-8.
9. Stojanovich L. Stress and autoimmunity. Autoimmun Rev 2010;9:A271-6.
10. Rosenbaum JT, Rosenzweig HL, Smith JR, et al. Uveitis secondary to bacterial products. Ophthalmic Res 2008;40:165-8.
11. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009;155:1-15.
12. Rosenbaum JT, Tammaro J, Robertson JEJr. Uveitis precipitated by nonpenetrating ocular trauma. Am J Ophthalmol 1991;112:392-5.
13. Knox DL. Alteration of patients' internal environment as a mode of treatment of an ocular inflammation. Jap J Clin Ecol 1995;4:29-31.
14. Taub SJ. Chronic uveitis due to sensitivity to common foods. Eye Ear Nose Throat Mon 1965;44:76.
15. Wildner G, Diedrichs-Möhring M. Autoimmune uveitis and antigenic mimicry of environmental antigens. Autoimmun Rev 2004;3:383-7.
16. Levinson RD. Immunogenetics of ocular inflammatory disease. Tissue Antigens 2007;69:105-112.
17. Zamecki KJ, Jabs DA. HLA typing in uveitis: use and misuse. Am J Ophthalmol 2010;149:189-93.
18. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200-9.
19. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology 2009;116:S30-6.
20. Smith JR, Spurrier NJ, Martin JT, et al. Prevalent use of complementary and alternative medicines by patients with inflammatory eye disease. Ocul Immunol Inflamm 2004;12:203-14.
21. Klareskog L, Padyukov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007;19:49-54.
22. Aronson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010;34:J258-65.
23. Knox DL. Pars planitis: a 20-year study of incidence, clinical features, and outcomes [letter]. Am J Ophthalmol 2008;146:479.
24. Siverio CD, Cubillan LDP, Cunningham ETJr. Smoking as a risk factor for vision loss due to cystoid macular edema in patients with idiopathic intermediate uveitis. Invest Ophthalmol Vis Sci 2001;42:S708.
25. Lois N, Abdelkader E, Reglitz K, et al. Environmental tobacco smoke exposure and eye disease. Br J Ophthalmol 2008;92:1304-10.
26. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64.
27. Dondaldson MJ, Pulido JS, Herman DC, et al. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol 2007;144:812-17.
28. Thorne JE, Daniel B, Jabs DA, et al. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol 2008;145:841-6.
29. Lin P, Loh AR, Margolis TP, et al. Cigarette smoking as a risk factor for uveitis. Ophthalmology 2010;117:585-90.
30. Boonman ZF, de Keizer RJ, Watson PG. Smoking delays the response to treatment in episcleritis and scleritis. Eye 2005;19:949-55.
31. Galor A, Feuer W, Kempen JH, et al. Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol 2010;94:848-53.
32. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.